- Details
- Written by USDA
- Category: Health News
Washington, DC - This week millions of Americans will gather family and friends around the dinner table to give thanks. But for those preparing the meal, it can be a stressful time. Not to mention, for many it is the largest meal they have cooked all year, leaving plenty of room for mistakes that could cause foodborne illness.
- Details
- Written by Dr. Stephanie Faubion
- Category: Health News
Rochester, Minnesota - For women who have their ovaries removed before 45 and before they reach menopause naturally (usually around 51 in the U.S.), menopausal hormone therapy, or MHT, often is recommended to prevent the negative effects of early estrogen loss.
- Details
- Written by IVN
- Category: Health News
Washington, DC - A new mouse model developed by scientists at the U.S. Food and Drug Administration may help in exploring the potential activity of Zika virus vaccines and therapeutics. Published today in PLoS Pathogens, is the description of a neonatal mouse model that provides a platform for potentially improving and expediting studies to understand the causes and effects (pathology) of the Zika virus.
- Details
- Written by Jazmine Wise
- Category: Health News
Falls Church, Virginia - The U.S. Navy's top doctor announced new strategic priorities for Navy Medicine, today.
- Details
- Written by IVN
- Category: Health News
Washington, DC - The U.S. Food and Drug Administration approved Intrarosa (prasterone) to treat women experiencing moderate to severe pain during sexual intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA), due to menopause. Intrarosa is the first FDA approved product containing the active ingredient prasterone, which is also known as dehydroepiandrosterone (DHEA).
Research on new, rapid screening test identifies potential therapies against drug-resistant bacteria
- Details
- Written by IVN
- Category: Health News
Washington, DC - Researchers at the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS), Clinical Center and National Institute of Allergy and Infectious Diseases (NIAID) have created a new way to identify drugs and drug combinations that may potentially be useful in combating infections that are resistant to many different antibiotics. They developed an assay (test) to rapidly screen thousands of drugs to determine how effective they were against a variety of types of resistant bacteria.
Page 74 of 374
